Skip to main content

HBT Financial Inc

For the period ended Dec 31, 2023. Filed Mar 6, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 6, 2024

HBT$37.47+1.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HBT FINANCIAL, INC.
Dated: March 6, 2024By:/s/ Peter R. Chapman
Peter R. Chapman
Chief Financial Officer
(on behalf of the registrant and as principal financial officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ J. Lance CarterPresident, Chief Executive Officer, and DirectorMarch 6, 2024
J. Lance Carter(Principal executive officer)
/s/ Peter R. ChapmanExecutive Vice President and Chief Financial OfficerMarch 6, 2024
Peter R. Chapman(Principal financial officer and principal accounting officer)
/s/ Fred L. DrakeExecutive Chairman and DirectorMarch 6, 2024
Fred L. Drake
/s/ Roger A. BakerDirectorMarch 6, 2024
Roger A. Baker
/s/ C. Alvin BowmanDirectorMarch 6, 2024
C. Alvin Bowman
/s/ Eric E. BurwellDirectorMarch 6, 2024
Eric E. Burwell
/s/ Patrick F. BuschDirectorMarch 6, 2024
Patrick F. Busch
/s/ Allen C. DrakeDirectorMarch 6, 2024
Allen C. Drake
/s/ Linda J. KochDirectorMarch 6, 2024
Linda J. Koch
/s/ Gerald E. PfeifferDirectorMarch 6, 2024
Gerald E. Pfeiffer
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.